5 patents
Utility
Treatment of pain and neurological conditions
24 Oct 23
Brady J. Granier, Jeffrey M. Witkin
Filed: 9 Feb 22
Utility
Treatment of Neurological Disorders
5 Oct 23
The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1, wherein compound 1 is N-[2,5-dimethyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide.
Brady J. Granier, Jeffrey M. Witkin, David Martirosyan
Filed: 1 Jun 23
Utility
Biodegradable Implant Including Naltrexone
30 Mar 23
A formulation of naltrexone that ameliorates undesirable localized reactions at the site of implantation.
Brady J. Granier, Ashok Kumar, Vitalii E Stelmakh, Robert P Giannini, JR., Andrew Peter Mallon, George Edward Sherman, JR.
Filed: 1 Apr 22
Utility
Treatment of Pain and Neurological Conditions
25 Aug 22
Brady J. Granier, Jeffrey M. Witkin
Filed: 9 Feb 22
Utility
Subcutaneous Biodegradable Naltrexone Implant And Accompanying Behavioral Program For Weight Loss In A Patient
21 Jan 21
Embodiments of the present disclosure provide methods, systems, and apparatuses for aiding weight loss in a patient.
Lourdes Felix, Brady James Granier
Filed: 29 Jun 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first